(Q51301047)

English

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

Joan L Walker

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Deborah K Armstrong

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Helen Q Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Jeffrey Fowler

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Kenneth Webster

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Robert A Burger

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Daniel Clarke-Pearson

7

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

100

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

27-32

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Catheter complications associated with intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

A case of protrusion of an intraperitoneal chemotherapy catheter through rectum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Complications associated with intraperitoneal chemotherapy catheters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Feasibility of intraoperative administration of chemotherapy for gynecologic malignancies: assessment of acute postoperative morbidity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Laparoscopical insertion of intraperitoneal catheters for intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Intestinal perforation secondary to paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.013

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.11.013

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/16368440

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51301047&oldid=1531845093"